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Summary 
Surgical site infections (SSIs) constitute about one quarter of all healthcare-
associated infections in Norway and are associated with a substantial cost for 
hospitals, patients and the community. Surveillance with feedback has been proven 
to be a useful tool in prevention of adverse events. In Norway, SSI surveillance was 
initiated through the establishment of the Norwegian Surveillance System for 
Antibiotic Consumption and Healthcare-Associated Infections (NOIS) by regulation in 
2005. 
 
The overall aim of this thesis was to describe and validate NOIS-SSI in order to 
ensure good data quality through a uniform, robust and feasible system for 
monitoring and controlling SSIs. This was achieved through three sub-studies, each 
reported in a separate paper. The first study gives a description of the methodology 
of NOIS-SSI, and the value of a mandatory system with automated data collection 
and post-discharge surveillance. The second study is an investigation of the 
completeness, representativeness and accuracy of the denominator data by 
comparing NOIS-SSI to administrative data. The third study is an investigation of the 
necessity of post-discharge surveillance and the consequences of differing duration 
and intensity of follow-up of patients after hospital discharge. 
 
Paper I reports a steadily increasing participation in NOIS-SSI during 2005-2009, 
with many hospitals implementing computerized systems and submitting extra data 
voluntarily. We found reasonable quality of the risk-adjustment variables and a very 
good post-discharge follow-up, with 81% of SSIs being detected after hospital 
discharge. Paper II shows that the completeness of NOIS-SSI's denominator data 
improved greatly between 2005-2010 and that hospital participation became more 
representative over time. However, NOIS-SSI did not achieve representativeness for 
all surgical procedures. The hospitals which participated, submitted accurate 
denominator data and all the computerized systems delivered data of high quality. In 
paper III, we found that 82% of the deep SSIs after hip arthroplasty in 2005-2011 
were detected after discharge from hospital. All of the patients with deep SSIs that 
were detected between 30 days and one year after hospital discharge were 
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readmitted, which means that they could have been detected through the hospitals' 
computer systems instead of by patient questionnaire. 
 
A mandatory surveillance system should give more complete and unbiased data than 
a voluntary system. NOIS-SSI was not complete and representative and this was 
mostly due to a flexible and incremental implementation strategy. The upside of this 
flexibility was the establishment of electronically based surveillance systems in 
almost all hospitals. Electronically based systems have led to good quality of risk-
adjustment variables and excellent accuracy. Because most SSIs are detected after 
hospital discharge, active follow-up of the patient after discharge is important for 
correct case ascertainment. Active follow-up is resource demanding, but without it 
most SSIs would go undetected and the infection rates would be incorrect. Validation 
of correct classification of SSIs according to surveillance definitions has not been 
performed in Norway. Some studies have indicated good-to-excellent sensitivity and 
specificity in SSI validation by retrospective chart review, whereas others have found 
poor inter-rater agreement. Information technology in surveillance is in rapid 
development, and much has been published about computer algorithm-assisted case 
detection in existing clinical and administrative databases. Although there are many 
potential pitfalls in utilizing more automated surveillance, it is time and cost efficient 
and circumvents many of the issues associated with manual systems. 
 
All-year, all-procedure mandatory surveillance was implemented in Norway from 
2012/2013. The findings of this thesis have led to changes in the Norwegian 
surveillance system, and one-year follow-of hip arthroplasty patients by letter will be 
replaced by surveillance through readmissions in 2015. By continually improving and 
upgrading the system we hope to achieve a surveillance system that is robust, 
efficient and useful. Acting on the basis of surveillance data in a clinical setting is the 
ultimate goal of a surveillance system. High quality data are essential in this process, 
and more use of automated case-finding may be an important asset in achieving this. 
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Abbreviations and definitions 
  
CDC Centers for Disease Control and Prevention 
ECDC European Centre for Disease Prevention and Control 
EHR Electronic health record 
HAI Healthcare-associated infection 
HELICS Hospitals in Europe Link for Infection Control through Surveillance 
ICD-9 International Classification of Diseases, 9th revision 
ICM Infection control module (computer software used in surveillance) 
ICP Infection control practitioner 
NHSN National Healthcare Safety Network (previously NNIS) 
NIPH Norwegian Institute of Public Health 
NNIS National Nosocomial Infection Surveillance System (now NHSN) 
NOIS Norwegian Surveillance System for Antibiotic Consumption and 
Healthcare-Associated Infections 
NPR Norwegian Patient Register (national administrative database for 
specialist health services) 
PDS Post-discharge surveillance (follow-up of patients after they are 
discharged from hospital) 
SIR Standardized infection ratio 
SSI Surgical site infection 
SENIC Study on the Efficacy of Nosocomial Infection Control 
WHO World Health Organization 
1 
 
1 Introduction and background 
1.1 General Introduction  
Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality 
in Norway and worldwide.1-3 In developed countries about 8-11% of in-patients4,5 
have a HAI at any point in time. HAIs are responsible for increasing healthcare costs 
and prolonged hospital stays for patients. Studies indicate as much as a doubling of 
costs of hospital stays because of HAIs.6-10 Longer life expectancy due in part to 
improved medical technology contributes to sicker, older and more fragile patients. 
Furthermore, the adverse developments in antibiotic resistance11,12 have increased 
the interest in prevention of infections. There has also been an increased attention 
given to HAIs as an important aspect of patient safety by politicians, patients and 
healthcare providers13-15 as well as public reporting of quality indicators.16-18 All of 
these issues have led to a strengthened interest in HAIs in the recent years. 
 
Surgical site infections (SSIs) account for about one quarter (23-28%) of the four 
most prevalent HAI types in Norway.3,19 It has been indicated that SSIs account for 
an additional median length of stay of ten days and a substantial increase in various 
hospital, community and patient costs.20-23 About 400,000 surgeries are performed in 
Norway each year.24 Recent data show that between 2.2% and 13.5% of patients 
who undergo surgery in Norway develop an SSI.25  
 
The purpose of this thesis is to investigate and document the data quality of the 
surgical site infection (SSI) module of the Norwegian Surveillance System for 
Antibiotic Consumption and Healthcare-Associated Infections (NOIS) in order to 
provide a basis for improvement of the system and proper interpretation and use of 
results from the system. In this background chapter I will describe the development of 
surveillance systems for SSIs, present the situation in Norway, define and explain 
central concepts of SSI surveillance, as well as describe the rationale and purpose of 
surveillance systems.  
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1.2 Surveillance of SSIs - why and how? 
1.2.1 What is surveillance? 
Surveillance is a tool used to detect and monitor epidemics and public health 
emergencies. Surveillance as a concept is attributed to William Farr’s work with the 
London cholera epidemic in the 1840s. 26,27 28,29 In the 1950s surveillance as a term 
began being used about watching diseases rather than individuals,30 and the 
definition of “the routine process of collection, collation and dissemination of health 
data” came about .28 In a more recent definition, public health surveillance is “the 
ongoing, systematic collection, analysis, interpretation, and dissemination of data 
regarding a health-related event for use in public health action to reduce morbidity 
and mortality and to improve health”.31 This definition encompasses an additional 
element, action (Figure 1). Surveillance is “information for action” and it is essential 
that the information (data) is of good quality in order to ensure that the end user 
trusts the output of the system in order for action to be taken.32 Without action being 
taken to prevent the occurrence of new adverse events on the basis of quality data 
there is little point in collecting, interpreting, and disseminating. Surveillance systems 
monitor trends, document the impact of HAIs, and evaluate the effectiveness of 
prevention efforts. SSIs are one type of HAI where surveillance with feedback has 
been shown to have good effect.33-38 
 
Figure 1. The surveillance loop 
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1.2.2 SSI surveillance, the international perspective 
The findings of the landmark Study on the Efficacy of Nosocomial Infection Control 
(SENIC),33 which was initiated in 1974 by the US Centers for Disease Control and 
Prevention (CDC), is the foundation and rationale for most of today's HAI surveillance 
systems. The SENIC project found a strong association between the establishment 
of surveillance systems with feedback and reduction in HAI rates, indicating that 
simply having such systems in place in the hospitals reduced HAI rates by as much 
as 32%. Following the SENIC project, the National Nosocomial Infection Surveillance 
System (NNIS) was introduced by the CDC in 1992.39 From 2005 it was included in 
the National Healthcare Safety Network (NHSN) which was established to integrate 
three existing surveillance systems. One aim of NHSN is to provide hospitals with 
comparable data. 
 
Many European countries established surveillance systems for HAIs during the 
1990s. The Hospitals in Europe Link for Infection Control through Surveillance 
(HELICS) project in 1994/95 was an initiative to, among other goals, standardize 
surveillance methods in order to generate comparable data in Europe.40,41 HELICS 
has collected SSI incidence data in a European database since 2004.42 The project 
was included in the portfolio of the European Centre for Disease Prevention and 
Control (ECDC) in 2008. The HELICS/ECDC protocol43 is based on the NHSN 
model. Many European countries have documented the positive effects of 
surveillance systems on HAI rates.37,44-46 HAI surveillance based on the CDC model 
is performed in many other countries worldwide.47  
1.2.3 SSI surveillance in Norway 
Calculating costs and burden of HAIs in Norway has previously been difficult 
because of the lack of good surveillance data. Prevalence surveys have been 
conducted in Norway since 19912 and on a regular basis semi-annually since 2002. 
However they are uncertain, as they only give data from one day. Point prevalence 
studies do not document risk factors and cause-and-effect relationships. In order to 
obtain better and more reliable surveillance data, prospective surveillance through 
NOIS was introduced by regulation in Norway in 2005.48 NOIS is one of 17 central 
health registers in Norway which have been established through the Personal Health 
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Data Filing System Act §8.49 These registers are nationwide and are governed by 
separate acts and have been established to ensure national functions (and do not 
require patient consent). 
 
The first module of NOIS was the surveillance of surgical site infections (NOIS-
SSI).50 NOIS-SSI was originally based on the HELICS project and NHSN definitions51 
and is described in the NOIS-SSI protocol.52 The objectives of NOIS are to describe 
the occurrence of healthcare-associated infections by time and other characteristics, 
detect outbreaks, provide a basis for preventive measures, and to evaluate such 
measures. The regulation requires that the data sent to the national database are de-
identified. This entails that personal identifiers such as name and personal 
identification number for each patient are removed before submission. NOIS is 
administrated by the Norwegian Institute of Public Health (NIPH). NOIS-SSI has 
three important key characteristics: 
1. It is a mandatory, national surveillance system 
2. It has a highly computerized data collection system in the hospitals  
3. It has an active, mandatory post-discharge surveillance (PDS) for 30 days 
(one year for implants) after surgery 
1.2.4 Hospital structure in Norway 
The Regional Health Authorities Act of 2002 led to a major reform of the specialist 
health care services in Norway with a transfer of the responsibility for all public 
hospitals from the county councils to the national government. Five Regional Health 
Authorities were originally set up to govern the specialist services within each of the 
health care regions. In 2007 south and east merged, leaving four (Figure 2). The 
Regional Health Authorities are owned by the Norwegian Ministry of Health and Care 
Services which appoints their board. The Regional Health Authorities own 21 
subsidiary healthcare trusts, each consisting of one or more hospitals, which provide 
the actual hospital services. In addition, some private specialist healthcare facilities 
are partners to the healthcare trusts on a contractual basis, and there are a few 
independent private hospitals. Six healthcare trusts have been approved as 
university hospitals, at least one within each Regional Health Authority. 
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There have been several closures and mergers of hospitals within the healthcare 
trust structure during the years, and what is considered a hospital is not consistent 
between trusts. For example, two separate hospitals may have merged into one 
hospital with two locations. This makes it difficult to report data on hospital level. The 
Directorate of Health's report on the specialist health services, 2012,24 uses 27 “units” 
whereof 20 healthcare trusts and seven individual hospitals. The size of hospitals in 
Norway varies from about 30 to 1300 beds, and about 43% of the beds are in 
surgical wards. The average length of hospital stay for surgical inpatients was 5.2 
days.24 About 4.7% of the patients were readmitted within seven days, and 10.4% 
within 30 days.24 
 
Figure 2. Norway’s Regional Health Authorities 
 
Source: Norway and health: An Introduction, The Ministry of Health and Care Services 
https://helsedirektoratet.no/publikasjoner/norway-and-health-an-introduction 
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1.2.5 Organization of infection control in Norwegian hospitals 
Infection control in Norwegian hospitals is governed by a regulation for infection 
control in healthcare.53 It requires that healthcare institutions have measures in place 
for infection prevention and control, including surveillance. It also states that an 
adequate number infection control practitioners are to be employed, and that these 
are to have sufficient time and resources available to perform the required tasks. 
Each Regional Health Authority is to have a competence center for healthcare 
associated infection prevention and control, led by an infection control physician. The 
competence center coordinates, supports, and stimulates infection control activities 
in the healthcare institutions. 
1.3 Objectives 
The overall aim of this project was to describe and validate the surveillance system in 
order to ensure good data quality which is an important element in ensuring a 
uniform, robust and feasible system for monitoring and controlling the occurrence of 
SSIs in Norway. This project was register-based, mostly utilizing data from NOIS-SSI, 
but also using administrative data. 
 
The project did not endeavor to evaluate and validate the whole surveillance system, 
but rather focused on certain important elements. This was achieved through three 
parts. Part one described the implementation of the system and the methods, and the 
completeness of reporting and the quality/accuracy of the collected data. Part two 
validated the denominator data, focusing especially on diverging systems and 
consequences for reporting. Part three explored the added value of active, 
mandatory post-discharge surveillance. 
 
“Good surveillance does not necessarily ensure the making of the right decisions, 
but it reduces the chances of wrong ones.”  Alexander Langmuir30 
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2 Materials and Methods 
2.1 Evaluating and describing data quality in a surveillance system 
Evaluation of the surveillance system is important in order to assess system 
performance and is an integral part of operating a surveillance system. It is important 
in promoting the best use of public health resources through the development of 
efficient and effective systems. In 2001 CDC published updated guidelines for 
evaluating public health surveillance systems;31 these have been considered the 
cornerstone in surveillance system evaluation in recent years. In 2006 the World 
Health Organization (WHO) published a guide to monitoring and evaluating 
communicable disease surveillance systems.54 In 2014 ECDC published a handbook 
for data quality monitoring and surveillance system evaluation,55 which builds on the 
previous guidelines by CDC and WHO. All of these guidelines define similar 
attributes and methodology, such as engaging stakeholders, describing the system, 
gathering evidence of the system's performance, making recommendations, using 
the findings, and sharing the lessons learned. The terminology may differ, but the 
basic concepts are similar. This project has mainly focused on the aspect of 
gathering evidence of the system's performance, more specifically, evaluation of data 
quality. The 2013 NHSN Data Quality Guidance and Toolkit for Reporting Facilities56 
states that validation of SSI surveillance data should include; (i) the completeness 
and accuracy of the procedure denominator, (ii) the quality of risk-adjustment 
variables and (iii) the completeness of case ascertainment and correct case 
classification. 
 
In this project we have evaluated data quality in NOIS-SSI by investigating: 
(i) The completeness and accuracy of  the procedure denominator by 
comparing NOIS-SSI with another data source, the Norwegian Patient 
Register (NPR) (paper II) 
(ii) The quality of risk-adjustment variables by describing the completeness of 
the data (paper I) and the representativeness and accuracy by comparing 
NOIS-SSI with NPR (paper II) 
(iii) The completeness of case-ascertainment by exploring the added value of 
active follow-up after hospital discharge (paper I and III) 
8 
 
 
The three studies in this project do not cover the comprehensive area, as described 
by NHSN, but focus on certain elements. Paper I also gives a general description of 
the functioning of the surveillance system. 
2.2 About NOIS-SSI 
NOIS-SSI covers several common surgical procedures (Table 1), as defined by the 
Nordic Medico-Statistical Committee's Classification of Surgical Procedures.57 To 
minimize the workload on the hospitals, a three-month surveillance period was 
established. September through November was chosen because this is a time of 
year with normal operation in the hospitals, no major holidays or other events which 
may disrupt the schedule. To encourage hospital participation, only data from the 
highest prioritized procedures under surveillance were required during the first years. 
From September 2012, mandatory surveillance of all five procedures and all year 
surveillance was introduced. Table 1 shows how the requirement for data submission 
to the NIPH has changed over time. In order to encourage the establishment of 
suitable computer based systems, exemption from submitting surveillance data was 
granted to hospitals during the first few years. 
 
Table 1. Changes in requirements for data submission to the National Institute of Public 
Health 2005-2015. Cell value for each procedure indicates level of priority in the 
surveillance system.  
 2005 2006 2007 2008 2009 2010 2011 2012-
2015 
Minimum number of procedures 
required 
1 1 1 1 1 2 2 All3 
Procedure and priority         
Coronary artery bypass graft 1 1 1 11 1 1 1 N/A 
Cesarean section 2 2 2 2 2 2 2 N/A 
Primary hip arthroplasty2 3 3 3 3 3 3 3 N/A 
Appendectomy 4 4 4 4 - - - N/A 
Cholecystectomy 5 5 51 51 4 4 4 N/A 
Colon surgery - - - - 5 5 5 N/A 
1 Mixed procedures excluded 
2 One year follow-up 
3 All procedures under surveillance 
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Post-discharge surveillance methods differ between countries in both intensity of 
case-finding and duration of follow-up after hospital discharge.58,59 In NOIS-SSI, all 
patients are followed up by patient questionnaire sent from the hospital about 25 
days after surgery (Figure 3), and an additional questionnaire after one year for hip 
arthroplasty. Data on SSI status is recorded at three postoperative intervals; 
discharge, 30 days and one year after implant surgery. We also register whether a 
patient has been readmitted (with or without a re-operation) due to an SSI within 30 
days and one year (for implants) of surgery. SSIs for non-hospitalized patients are 
confirmed by a physician, either the patient's general practitioner or at a hospital 
outpatient clinic. Patient-reported infections are also collected, but these are coded 
separately. The patient-reported infections are not included in this project for several 
reasons: surgeons are generally skeptical to them, we are unsure of the quality of 
reporting from the hospitals, and these data are not comparable with most other 
countries. 
 
Figure 3. Points in time for recording information during 30-day and one year follow-up 
in NOIS-SSI. 
 
 
The key measure in NOIS-SSI is the incidence proportion of SSIs (herein also 
denoted as SSI rate). This is defined as the proportion of patients who develop an 
SSI within 30 days after surgery (one year for implant surgery). The quality of this 
measure depends of correct counting of number of patients who have undergone 
surgery (the denominator) and the correct identification of patients who develop an 
SSI (the numerator).  
 
NOIS-SSI collects information on several variables which capture the risk of both 
patient related and other risk factors that may explain, confound or modify the risk of 
infection and is based on the CDC/ECDC protocols (Table 4). This information may 
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be used for identifying causes of infection or for risk adjustment in between-hospital 
comparisons. A combination of some of these variables make up the NHSN risk 
index, and have previously been proven to be a simple and fairly robust for risk 
adjustment60,61. It originally consisted of three factors (1) the condition of the patient 
(American Society of Anesthesiologists (ASA) score), (2) surgical wound 
contamination classification, and (3) duration of surgery is longer then the 75th 
percentile. It was later modified to include a factor for risk reduction in endo- or 
laparoscopic surgery. In 2010, the NHSN introduced a new method of risk 
adjustment, the standardized infection ratio (SIR). 62 The SIR uses several risk 
factors which have been identified through logistic regression modelling to provide 
better risk adjustment than the NHSN risk stratification. It allows for all available risk 
factors to be included, as well as allowing the risk factors to be procedure specific.  
 
The NOIS group at the NIPH organizes an annual “surveillance day” for ICPs (and 
surgeons). At this meeting the latest data are presented, problems with data 
collection and quality are discussed and dissemination experiences are shared. 
Because Norway is a small country with only about 50-60 hospitals which perform 
surgical procedures, most hospitals participate with at least one representative. This 
is an excellent opportunity for networking and exchanging experiences. In 
conjunction with the surveillance day there is also a meeting of the NOIS reference 
group. This group consists of representatives from the infection control community 
and surgeons from the different surgical specialties under surveillance. The main 
purpose of the reference group is to give advice on system functioning, maintenance 
and future directions. 
2.2.1 NOIS-SSI in the hospitals 
One of the objectives when implementing NOIS-SSI was to utilize as much of the 
existing data in hospital information systems as possible, in order to limit the burden 
on hospital staff and ensure good data quality. The resources used to operate NOIS-
SSI in the hospitals vary greatly, depending on the sophistication of the IT-systems 
and the organization of the data collection and feedback. In a Master’s thesis from 
2010, 63 ICPs report large variations in time spent on data collection and quality 
assurance, from 1-2 days per month to full time. Data collection was mostly done by 
infection control nurses and secretaries, and quality checks by infection control 
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nurses. Interpretation and dissemination of data was primarily done in approximately 
equal parts by infection control doctors, infection control nurses and surgeons. 
 
Some of the Norwegian hospitals had already implemented surveillance systems with 
data harvesting from underlying systems when the national system was initiated. 
These systems were used as templates when establishing the national database and 
protocol. Because the hospitals and health care regions had different suppliers of 
information systems, several different infection control modules (ICMs), were 
developed. The systems utilize data extracted from different sources. The most 
common method is to use patient and risk adjustment data extracted from 
administrative sources, such as the patient record, combined with the surgery 
planning system and anesthesiology system. 
 
There are three major suppliers of ICMs in Norway and several in-house systems. 
Some systems are developed by the electronic health record (EHR)-supplier and are 
integrated in the EHR-system work flow, and some are “stand-alone” systems that 
harvest data from other system suppliers. The trend is towards fewer and more 
professional ICM systems. None of the Norwegian systems include automated 
identification of infections. Some efforts have been made to assist case identification 
by tagging potential infections on the basis of microbiology or pharmacy data, but 
none have been successfully implemented.  
 
How the ICM interacts with the users varies between systems and hospitals. Some 
are decentralized, and the individual surgical units ensure case identification, post-
discharge surveillance (PDS) and proper collection of data, with the infection control 
practitioner (ICP) providing coordination and final quality assurance. Some are very 
centralized, with the ICPs performing the case-finding, PDS and quality assurance 
tasks. Some ICMs have advanced report modules which display statistics and 
graphics, and some do not. 
 
The ICM ensures de-identification by giving each procedure a unique number. This 
key allows the ICP to identify the patients for quality assurance, while it ensures that 
the data that are transferred to the national level are de-identified. The ICM 
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generates export files in a specific format, which can be easily imported into other 
systems. 
2.2.2 The national NOIS-SSI database 
The national database is located at the NIPH and receives de-identified data in 
batches from the hospitals at set times during the year. Until 2012, when data were 
collected only during September-November, data were submitted annually. The 
deadline for submitting data was usually March, and the annual report would be 
published by the NIPH in June. The original database was not accessible from 
outside the NIPH, so data had to be sent on CDs, memory sticks or by encrypted e-
mail. The data files were uploaded to the national database by NIPH personnel. The 
NIPH database contained many validation rules and checks to ensure the quality and 
consistency of the data. These validation rules were made available to the ICM-
suppliers, so they could implement similar checks in the hospital ICMs. The NIPH 
has an extensive dialog with the hospitals’ ICPs regarding quality assurance of the 
data and the hospitals receive reports on data quality, such as percent of missing 
values for each variable and post-discharge follow-up rate, after each data collection 
period. 
2.3 Paper I 
Title: Methodology of the Norwegian Surveillance System for Healthcare-Associated 
Infections: The value of a mandatory system, automated data collection, and active 
post-discharge surveillance 
 
In this paper we aimed to describe and explain the functioning of NOIS-SSI in a 
national perspective. Firstly, we examined reporting compliance and how the nature 
of the system has affected reporting. Secondly, we aimed to evaluate the 
effectiveness of automated data collection. Thirdly, we aimed to evaluate the added 
value of active post-discharge surveillance by patient questionnaire. 
 
We used national data on surgical procedures collected during the first five years of 
operation (2005-2009), and used the following measures: We documented reporting 
compliance by investigating what proportion of the hospitals submitted data on the 
different procedures for each year. The effectiveness of automated data harvesting 
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was documented by investigating the percentage of missing data for the risk-
adjustment variables overall and for those which were included in the NHSN risk 
index.60 The impact of post-discharge surveillance was evaluated by investigating the 
proportion of procedures with complete 30-day follow-up and the proportion of these 
which developed an SSI.  
2.4 Paper II 
Title: The quality of denominator data in surgical site infection surveillance versus 
administrative data in Norway 2005-2010 
 
The objective this paper was to investigate denominator data quality by comparing 
SSI surveillance data from NOIS-SSI with administrative data from the Norwegian 
Patient Register (NPR)64,65 in order to explain discrepancies and recommend 
improvements. 
 
We used de-identified data from four surgical procedures from 2005-2010. In 
evaluating completeness and representativeness we used all procedures during the 
three-month NOIS-SSI surveillance window and all procedures in NPR for the same 
period. Completeness was evaluated by dividing NOIS-SSI by NPR. 
Representativeness was investigated by comparing the distribution of data in the two 
registers by hospital size and type, region, age, sex. In investigating accuracy we 
restricted the comparison to hospitals and reporting months which were present in 
both registers, and used the same variables as above. In addition accuracy was 
investigated with regard to which IT-system for surveillance was used by the 
hospitals. Differences in the distribution between the registers were evaluated using 
chi-squared analysis. 
2.5 Paper III 
Title: Surgical site infections after hip arthroplasty in Norway 2005-2011: Influence of 
duration and intensity of post-discharge surveillance 
 
The norm for PDS duration after hip arthroplasty has been one year until CDC's 
NHSN from 2013 reduced this to 90 days.66 The balance between the wish for high 
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quality data and the resource demands of diligent PDS at both 30 days and one year 
was the focus of paper III. We investigated how long it is necessary to follow up hip 
arthroplasty patients for SSIs after surgery and if passive PDS can be used in lieu of 
active PDS to detect SSIs. 
 
We used 2005-2011 NOIS-SSI hip arthroplasty data with one year follow-up and 
readmission data. We investigated the effect of the duration of PDS on the incidence 
rates and the proportion of SSIs detected before and after discharge and at different 
postoperative time intervals. The influence of the intensity of PDS was assessed by 
investigating the proportion of deep SSIs detected by patient questionnaire (active 
PDS) compared with SSIs which could have been detected solely through 
readmissions (passive PDS). We used one year active PDS as a proxy “gold 
standard” and calculated sensitivity with 95% confidence intervals (Adjusted Wald) 
for different postoperative time intervals and case-finding strategies. We here defined 
sensitivity as the proportion of all infections in the one-year observation window that 
would have been detected already at the other time intervals and case finding 
strategies. 
2.6 Ethical issues 
NOIS-SSI is de-identified and is governed by a separate act,48 and patient consent is 
not required. NPR was also de-identified at the time the data were extracted for this 
project, and is also governed by a separate act64 and does not require patient 
consent. The study which compares NOIS-SSI and NPR (paper II) was approved by 
the Regional Committee for Medical and Health Research Ethics. 
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3 Summary of results 
3.1 Describing the functioning of the system, the quality of risk adjustment 
variables and the value of post-discharge surveillance (paper I) 
3.1.1 The functioning of the system - compliance 
During the first five years of operation, participation in NOIS-SSI increased from 
about half of the hospitals to almost all. In 2005, data on 2,371 individual procedures 
were submitted, increasing to 6,089 in 2009. The majority of the procedures were 
primary hip arthroplasties and cesarean sections. The proportion of hospitals 
submitting data from more than one procedure voluntarily increased steadily from 
under half of the hospitals in 2005 to over two thirds in 2009 (Figure 4), and the 
procedures with the highest priority showed the greatest increase. 
 
Figure 4. Number of surgical procedure types under surveillance by hospitals in NOIS-
SSI 2005-2009 
  
3.1.2 The quality of risk adjustment variables 
23.3% of the records had at least one missing value for the risk-adjustment variables.  
Antibiotic prophylaxis and wound contamination class were the most important 
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contributors to the proportion of missing data. 6.8% of the risk-adjustment variables 
that were included in the NHSN risk index were missing in 2005-2009. 
3.1.3 The value of post-discharge surveillance 
Overall, 90.7% of the procedures had complete post-discharge follow-up (PDS) and 
81% of the SSIs with complete PDS were detected after hospital discharge (Table 2). 
There was a large variation between procedures in which proportion of SSIs were 
detected post-discharge. 
 
Table 2. Proportion of patients with complete follow-up and proportion thereof of 
infections detected after hospital discharge, totals NOIS-SSI 2005-2009 (modified from 
table 1 and 2 in paper I) 
Procedure Complete 
follow-up, % 
Detected after 
discharge, % 
Coronary artery bypass graft 92 94 
Cesarean section 88 83 
Primary hip arthroplasty 96 76 
Appendectomy1 74 73 
Cholecystectomy 89 75 
Colon surgery2 84 50 
Total 91 81 
1 Surveillance discontinued from 2009   
2 Surveillance started in 2009   
 
3.2 Completeness, representativeness and accuracy of the procedure 
denominator (paper II) 
3.2.1 Completeness and representativeness 
The completeness of NOIS-SSI improved from 29.2% in 2005 to 79.8% in 2010 as 
compared with NPR. In 2010, cesarean section had the best completeness (96.1%), 
followed by hip arthroplasty (81.7%), coronary artery bypass graft (76.9%) and 
cholecystectomy (44.2%). 
 
NOIS-SSI's data quality in terms of representativeness improved during the study 
period. Figure 5 shows how the distribution by hospital size differed significantly from 
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NPR during the first years of operation, but became more similar in the latter years 
especially for the highest prioritized procedures. It also demonstrates changes in 
healthcare trust structure, with a tendency to report data from larger units rather than 
from individual hospitals in the latter years. Hospital type (data not shown) shows a 
similar pattern. By regional distribution NOIS-SSI did not achieve representativeness, 
with a few sporadic exceptions. It was representative with regard to age and sex for 
all years and procedures. 
 
Figure 5. Representativeness: Proportion of procedures  (in %) by hospital size in 
NOIS-SSI and NPR (2005-2010) by type of procedure (CABG: Coronary artery bypass graft, 
CSEC: Cesarean section, HPRO: Primary hip arthroplasty, CHOL: Cholecystectomy) 
 
3.2.2 Accuracy 
When we compared only hospitals and reporting periods that were present in both 
registers the overall accuracy for all years was 94.8%. In 2010, cesarean section and 
hip arthroplasty had an accuracy of 98.8%, followed by coronary artery bypass graft 
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with 93.9% and cholecystectomy with 90.0%. There were no significant differences 
between regions, hospital type and size, age or sex for each year and procedure. All 
electronic and other surveillance systems in the hospitals performed well. 
3.3 Case-ascertainment through post-discharge surveillance (Paper III) 
In this study of SSIs after primary hip arthroplasty in Norway, using data from NOIS-
SSI with one year active PDS, we found that 79% of all SSIs were detected after 
hospital discharge and 82% of deep SSIs. 95% of all SSIs were detected within 90 
days after surgery (Figure 6). The overall SSI rate was 3.6%, 2.8% for total hip 
arthroplasty and 5.9% for hemiarthroplasty. We observed a reduction in the median 
postoperative length of stay from seven (2005-2008) to five (2009-2011) days for 
total hip arthroplasty and from eight to six days for hemiarthroplasty. We also 
observed that the proportion of deep SSIs detected after discharge increased from 
79% in 2008-2008 to 85% in 2009-2011. 
 
Figure 6. Number of days to SSI* and percent of infections detected at different points in 
time after total hip arthroplasty (THA) and hemiarthroplasty (HA) by SSI type, NOIS-SSI 
2005-2011 
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All 18 deep SSIs which were detected between 31 days and one year after surgery 
were readmitted because of their SSI and thus could have been detected by passive 
PDS. Active PDS for the first 30 days and passive PDS thereafter achieved the same 
sensitivity as active PDS for one year for deep SSIs (Table 3). 
 
Table 3. Deep SSI* rates and sensitivity of case-finding using different surveillance 
durations and intensities, NOIS-SSI 2005-2011 
 
 
Surveillance method
Deep 
SSIs
SSI 
rate %
Sensitivity
 (95% CI)
Deep 
SSIs
SSI 
rate %
Sensitivity
(95% CI)
Deep 
SSIs
SSI 
rate %
Sensitivity
(95% CI)
Active PDS for one year 61 1.2 Ref 70 4.3 Ref 131 2.0 Ref
Active PDS for 90 days 57 1.2 0.93 (0.84-0.98) 67 4.1 0.96 (0.88-0.99) 124 1.9 0.95 (0.89-0.98)
Active PDS for 30 days 53 1.1 0.87 (0.76-0.93) 60 3.7 0.86 (0.75-0.92) 113 1.7 0.86 (0.79-0.91)
Active for 30  days and 
passive to one year
61 1.2 1.00 (0.93-1.00) 70 4.3 1.00 (0.94-1.00) 131 2.0 1.00 (0.97-1.00)
Active for 30  days and 
passive to 90 days
57 1.2 0.93 (0.84-0.98) 67 4.1 0.96 (0.88-0.99) 124 1.9 0.95 (0.89-0.98)
Passive PDS for one year 52 1.1 0.85 (0.74-0.92) 60 3.7 0.86 (0.75-0.92) 112 1.7 0.85 (0.78-0.91)
Passive PDS for 90 days 48 1.0 0.79 (0.67-0.87) 57 3.5 0.81 (0.71-0.89) 105 1.6 0.80 (0.72-0.86)
Passive PDS for 30 days 44 0.9 0.72 (0.60-0.82) 50 3.1 0.71 (0.60-0.81) 94 1.4 0.72 (0.63-0.79)
Inpatient only 6 0.1 0.10 (0.04-0.20) 18 1.1 0.26 (0.17-0.37) 24 0.4 0.18 (0.13-0.26)
* SSIs with missing infection date excluded
Total hip arthroplasty Hemiarthroplasty Total
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4 Discussion 
Surveillance of surgical site infections, as with any surveillance, should be 
information for action. Action to prevent SSIs should be taken by the clinical teams in 
the hospitals. For them to act upon information from surveillance, they must trust the 
data and feel ownership of the surveillance system. The work described in this thesis 
endeavors to increase the understanding of the functioning and data quality of 
surgical site infection surveillance in Norway in order to encourage more active use 
of the data in prevention efforts. 
 
Specifically we have: 
• Described the implementation of the system and the methods, and the 
completeness of reporting and the quality/accuracy of the collected data 
(paper I). 
• Validated the system denominator, focusing especially on diverging 
systems/infrastructure and consequences for reporting (paper II). 
• Explored the added value of active, mandatory post-discharge surveillance 
(paper III). 
4.1 The overall methodology of the surveillance system 
The protocols used in SSI surveillance have been fairly uniform between countries, 
and in Europe especially in recent years with the establishment of a European 
protocol by ECDC.43 Many SSI surveillance systems worldwide are based on the 
CDC’s methodology.47 Despite a common methodology, there are large differences 
in the degree of implementation, rules and regulations, financing, culture, 
interpretation, and local adaptations between countries. Direct comparison of SSI 
rates is therefore generally not reliable. Even within fairly similar European systems, 
the discrepancies make comparisons difficult.67,68 
4.1.1 Mandatory versus voluntary surveillance 
A national mandatory surveillance system will give a broader and better overview of 
the infection status in a country in comparison with a voluntary system, and will 
instigate surveillance activity in hospitals that would not otherwise participate.69 In a 
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review of four national systems, Haustein et al70 found that the proportion of hospitals 
voluntarily reporting never surpassed 50%. Additionally, in voluntary systems, the 
participant population will change over time as hospitals join, leave, and rejoin the 
system. Hospitals which participate voluntarily may not be representative of the 
country as a whole.68,71 There is evidence that smaller hospitals may be more 
reluctant to participate.5,72,73 It may be presumed that small hospitals have fewer 
ICPs and may not have the resources to implement surveillance. Also, very small 
hospitals will perform very few procedures, and the calculation of incidence 
proportions and other statistics may not be perceived as useful to the hospital. 
4.1.2 Flexibility in reporting of procedures 
Our data show an increase in the proportion of hospitals that submitted data for more 
than the mandated minimum of number procedure types (Figure 4). Most hospitals 
started with the required minimum of one type of procedure, but many exceeded the 
minimum requirements and included more procedures voluntarily as routines came 
into place. This can be interpreted as the hospitals finding the surveillance useful, 
and therefore submitting more procedures voluntarily. Only five Norwegian hospitals 
perform all five procedures and six small or specialized hospitals perform only one of 
the surveillance procedures.  
 
A mandatory system may give poorer data quality because hospitals are required to 
participate even when they do not have the resources available to have a good data 
collection system in place.  Voluntary systems may provide more enthusiastic 
participation, but may also be prone to selection bias.69,70,74 
4.2 Completeness and accuracy of the procedure denominator 
The main focus of validating outcome measures of SSI surveillance has been 
application of surveillance definitions to identify cases.  Validating the quality of the 
denominator (number of procedures) has received much less attention. Denominator 
data are important in order to reliably describe occurrence on a national level, 
benchmarking, and inter-country comparisons. Regardless of how diligent case-
finding is, incidence proportions and rates only make sense if the correct 
denominator is used.75,76 Comparison of denominator data between registers can 
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give an indication of the quality of the data in both registers and reflect the quality of 
the data extraction at the individual hospital. 
 
There are very few studies that validate the denominator data of SSI surveillance 
systems. In Scotland77 researchers found that 91% of eligible procedures were 
included in the surveillance data. In the US (New York)78 researchers found 98% 
matches between administrative data and surveillance data. A study from England 
found that the surveillance database contained 95% of the procedures that were 
recorded in the patient administration system.79 In a recent review the accuracy of 
administrative coding80 none of the included studies mention the quality of the 
denominator data.81-89 Several Norwegian studies have evaluated the quality of 
different registers against NPR and found good completeness.90-95 As in other 
countries, there has been a discussion in Norway about hospitals using "creative 
coding" practices in order to gain financial benefit from administrative/billing data, and 
thus undermining the quality of NPR data. An investigation by Norway’s Office of the 
Auditor General in 200896 found that the hospitals claimed refunds for 2.7% more 
procedure codes than they were entitled to. 36.2% of main diagnosis codes were 
miscoded. Correcting for miscoding led to a reduction in refunds to the hospitals by 
5.2%. Weak coding practices may undermine the usefulness of patient statistics for 
planning, evaluating and governing of the health services and limit the usefulness of 
the data for surveillance and medical research purposes. 
 
Despite their potential weaknesses, hospital databases are increasingly being used 
to capture data, with the intention of replacing resource demanding manual tasks. 
Because SSI surveillance is patient based, denominator collection is not as complex 
as for other types of HAI, such as device-associated infections which use aggregated 
device data.75 In SSI surveillance, the numerator and denominator are tied together. 
If, for example, all procedures with a specific procedure code are not harvested 
because of a computer flaw, both numerator and denominator will be lost. If this was 
a procedure code with a higher (or lower) risk of infection, the remaining data would 
be biased. 
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4.2.1 Completeness and representativeness 
The completeness of NOIS-SSI denominator data was poor compared with NPR 
during the first years, but improved over time. The data were also not representative 
during the first years when we compared region and hospital type and size. This is 
partly due to many hospitals being granted exemption, which led to several regions 
and trusts submitting little or no data, and that the same hospitals did not participate 
each year. The system by which the hospitals were required to submit the highest 
prioritized procedure(s) may be another contributor to NOIS-SSI not being 
representative is (Table 1). This led to under-representation of some lower priority 
procedures. An example of this is large university hospitals being required to report 
on coronary artery bypass graft (only 6 hospitals perform this surgery) and thus some 
not reporting on cesarean sections, leaving fewer cesarean sections reported from 
large university hospitals. NOIS-SSI was representative by age and sex for all years. 
 
NOIS-SSI only collected national data during September-November during the 
project period. The ECDC reports on Surveillance of Surgical Site Infections in 
Europe show no trend towards a reduction in incidence proportions for SSIs in the 
Norwegian data during 2006-200997 and 2008-2011,98 as observed in some other 
countries. We believe that this is at least in part due to the three-month surveillance 
period. Only operating for three months at a time means hospitals have to “reset” the 
system each year which may have this unfortunate effect.99 It may be argued that 
such cyclical surveillance, rather than all year focus, leads to less attention on SSI 
prevention during the remainder of the year. Some have shown that it takes time to 
achieve the "surveillance effect"44,45,100-102 and that the greatest effect is in the first 
few years,37,100 whereas others do not find an effect over time.103,104 The UK and 
France,74,105 like Norway, have systems where surveillance is only required for some 
months of the year.106 Both these countries show a reduction in the incidence 
proportions only for some procedures in the ECDC reports, and may be experiencing 
the same issue as with the Norwegian data. In other French and UK studies, 
however, an overall reduction in SSIs over years is shown.35,107-109 Some hospitals in 
Norway performed all-year surveillance voluntarily, but these data have not been 
reported to the national level. Many said that they found it more resource demanding 
and inefficient to stop and restart the surveillance system than to operate it all year. 
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Keeping abreast of training of new personnel and updates to computer systems were 
reported as easier with all-year surveillance. 
 
Another issue with only collecting data during a three-month period is seasonal 
variation. Additional NPR-data show that 28% of our procedures under surveillance 
were performed during the September-November surveillance window, a relatively 
larger proportion than during the other three-month periods. This is especially true for 
elective procedures, as these are not performed during holiday periods, and must be 
taken into account in analyses and interpretation. 
 
The importance of representative data depends on how the surveillance data are to 
be used. For evaluating risk factors and implementing preventive measures in the 
individual hospitals, representative data on a national level are not of great 
importance. For benchmarking and public reporting representative data are very 
important. As commented in the review of four surveillance systems by Haustein et 
al70, mandatory reporting is recommended in order to assure that data are not 
biased. NOIS-SSI has mandatory reporting, but as long as hospitals are not required 
to submit all procedures, it will not be fully representative by hospital size and type. 
Although NOIS-SSI has been mandatory since inception, implementation was 
incremental, creating much of the selection bias one might expect to see in a 
voluntary system. 
4.2.2 Data source agreement and accuracy 
When we compared only hospitals and months which were present in both NOIS-SSI 
and NPR, we found good agreement between the two registers for all the risk-
adjustment variables. This means that when the hospitals did submit data they 
appeared to contain the correct number of records and were accurate. This implies 
that the way the ICMs harvest the data from hospital subsystems is good. It is, 
however, difficult to assess true agreement without having access to linked data. 
 
Investigations need to be done on a regular basis in order to assure that the number 
of procedures received from the hospitals is correct. There are some examples of 
problems with data collection in NOIS-SSI. One example is seen clearly in paper II 
where the accuracy for cesarean sections in 2008 is lower than the other years. This 
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was discovered retrospectively and located to two hospitals having incomplete data 
extraction. We have also discovered some instances of hospitals inadvertently only 
submitting total hip arthroplasties, and omitting hemiarthroplasties because of 
protocol misunderstandings. Similarly, some hospitals have only submitted non-
mixed coronary artery bypass graft procedures because of misunderstandings. 
These types of omissions are difficult to discover without consistency analysis or 
comparisons with other data sources. The magnitude of such errors is probably not 
very large in Norway, but this is difficult to ascertain without linked data. The 
consequences of the errors will vary. In the case of the cesarean sections, it will 
probably have few consequences, as there is no reason to believe that there is a 
systematic difference in infection risks between months. In the case of the hip 
arthroplasties and bypass surgery the consequences may be greater because the 
procedures which were lost had higher risk of infection,110,111 and therefore the 
reported incidence rates would consequently be lower for these hospitals. 
4.3 The quality of the risk-adjustment variables 
Risk adjustment indexes for SSI rates have existed for decades,112 and the NHSN 
risk index was in use from 1991.60 Much attention has been given to evaluating and 
optimizing the NHSN risk index over the years.113-117 Some advantages of the NHSN 
risk index were its simplicity and transparency, and disadvantages included its 
inability to sufficiently differentiate for some types of surgery where patients and 
procedures are very homogenous. The variables that were included in the NHSN risk 
index were generally easily available in hospital computer systems, and although 
other variables may be better predictors, they are not necessarily easily available or 
of good quality.118 With the introduction of the NHSN’s standardized infection ratio 
(SIR) in 2010, more variables were included in the risk adjustment algorithm.62 One 
of the advantages of this was that the included risk stratification variables could be 
tailored for each specific procedure. The original NHSN risk index variables are 
included in the SIR and some additional predictive factors have been added. New 
risk factors include patient related elements (e.g. age, sex and body mass index), 
and structural elements (e.g. hospital size and university affiliation). 
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Paper I shows that 23.3% of the records in NOIS-SSI had at least one missing value 
for the risk-adjustment variables in 2005-2009. Most were attributable to missing data 
on antibiotic prophylaxis (21.0%). As can be seen in Table 4, NOIS-SSI’s data quality 
is generally good as compared to the European average.97 In NOIS-SSI we have 
identified the key variables that generate the most missing values and have worked 
systematically to improve these. We have strived to achieve a high degree of 
completeness of risk-adjustment variables by encouraging implementation of 
computer systems in hospitals. It is, however, difficult to improve the quality of the 
risk-adjustment variables if they are not available or correct in the underlying 
computer systems. There is a considerable resistance among ICPs and other 
hospital personnel to manual coding when they expect the computer system to be 
able to harvest these variables correctly. The complexity of collecting data from 
diverging subsystems can be underestimated and creates extra demand for a good 
dialog with IT personnel. Misunderstandings, small programming errors and 
systematic errors in data input can mean poor data quality and can have major 
consequences. Accuracy can be improved through checks and subroutines that are 
programmed into the ICMs. Incorrect coding of variables in the source system is an 
issue, but the same would apply to a manual surveillance system. 
 
Another potential problem area in utilizing automated data collection is the use of 
default values in computer systems. An example of this would be automatically 
coding all total hip arthroplasties as "clean" procedures (wound class 1) by default 
because this would be correct in most cases. One would then expect hospital staff to 
change the coding where this is applicable, but in many cases this will not be done. 
Although the intentions are good, this type of practice is difficult to detect and can 
lead to risk-adjustment being erroneous. We have also seen differences in manual 
coding practices because of non-uniform interpretation of risk-adjustment variables in 
different hospitals. It is very difficult to assess the magnitude of this type of problem 
and its impact on outcomes. 
 
27 
 
Table 4. Percent of missing values in ECDC’s HAI-Net and NOIS-SSI by variable and 
time period  
 ECDC HAI-Net NOIS-SSI 
 13 countries, 
655,000 records 97 
26,000 records 
Variable 2008-2009 2005-2009 
Overall N/A 23.3 
Sex 0.2 <1.0 
Age  <1.0 
Antibiotic prophylaxis 63.6 21.0 
Urgent or elective surgery 25.2 4.5 
NHSN risk index procedures N/A 6.8 
Endoscopic procedure 1.9 01 
Wound contamination class 1.1 5.3 
Duration of surgery 3.1 <1.0 
ASA2 physical status 4.8 1.7 
1 Included in the surgical procedure code (NCSP) 
2 American Society of Anesthesiologists119 
 
In collaboration with the Norwegian Arthroplasty Register we examined the risk 
factors for infection after total hip arthroplasty and hemiarthroplasty.110 Both systems 
collect many of the same background variables, but through different channels. 
Although the NOIS-SSI data were from a three-month period and not all hospitals 
were included (completeness issues), the adjusted risk of SSIs in NOIS-SSI 
supported the adjusted risk for revision due to infection in the Norwegian Arthroplasty 
Register for many of the risk-adjustment variables. This supports the general 
impression that the risk-adjustment variables in NOIS-SSI are of good quality. 
 
Taking the above into consideration, it is interesting to note the lack of focus in the 
literature on the data quality of risk-adjustment variables and how these data are 
collected. No matter how well an index is constructed, it is of little value if the quality 
of the included variables is insufficient. In our experience, collection of risk variables 
is a resource demanding and important component of surveillance. Benchmarking 
and public reporting cannot be properly stratified without this information being of 
good quality.120-122 Norway has not yet introduced the SIR, and the Norwegian data 
have not  been formally used for public reporting at hospital level, although we have 
published reports with between-hospital comparisons.25 Many of the NHSN SIR 
patient related risk factors are available and of good quality in the NOIS-SSI and the 
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structural elements, such as hospital size and type, are easily available. Constructing 
an SIR adapted to Norwegian conditions would be possible and very useful. 
4.4 Completeness of case-ascertainment and correct case-classification 
Detecting cases according to stringent definitions51,66 is a main component of 
surveillance systems. Surveillance of most types of HAIs is generally only done in the 
hospital setting, but for SSIs case ascertainment is complicated further by the fact 
that infections may become clinically manifest after the patients are discharged from 
hospital.108,123-129 A paradigm shift towards shorter length of hospital stay and more 
day-surgery (no overnight stay) has made PDS even more important in detecting all 
infections.130-132 The OECD found a reduction in overall average length of stay from 
8.2 to 7.2 days from 2000 to 2009133 (Figure 7). Figure 8 shows how overall mean 
length of stay has decreased in Norway during the last decades from about eight 
days in 1990 to about four in 2010 for all hospitalizations.24 These trends are even 
more prominent in surgery because of advances in surgical techniques which lead to 
more day surgery, shorter recovery and shorter length of stay.134 We found a 
reduction in postoperative length of stay from seven to five days for total hip 
arthroplasties and eight to six days in hemiarthroplasties in paper III. 
 
Figure 7. Average length of hospital stay in hospitals for all causes, 2000 and 2009 
OECD countries133 
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Figure 8. Average length of hospital stay in acute care hospitals in 1974-2012, Norway24 
 
4.4.1 Case ascertainment 
Post-discharge follow-up is an important, resource demanding and complicated 
aspect of incidence surveillance of SSI,124,135 and concern has been raised with 
regard to "surveillance fatigue" that may result in less diligent case-finding by 
traditional methods over time.136 Active PDS by patient questionnaire is labor 
intensive and passive PDS has been associated with sacrificing sensitivity in case-
finding.137,138 The extensive use of electronic health records in hospitals makes it 
appealing to passively use data that already exists (passive PDS).80,139-141 In paper III 
we specifically investigated whether one-year follow-up of primary hip prosthesis by 
patient letter (active PDS) was necessary in order to detect all SSIs, and found that it 
was not. Although SSIs may manifest several years after surgery,142,143 several other 
studies have found that patients with deep SSIs that manifest late (more than 30 
days after surgery) will return to hospital because of symptoms or complications, and 
thus active PDS is not necessary in order to detect these SSIs.137,144,145  
 
However, this is not the case for 30-day follow-up, where active PDS is very 
important. In papers I and III we found that a substantial proportion of SSIs were 
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detected after hospital discharge (Table 2). We found that about half the SSIs after 
hip arthroplasty would not have been detected without active PDS. Because of 
increasingly shorter length of stay, the completeness of case ascertainment is closely 
related to the method, duration and intensity of PDS. Active PDS is necessary 
because many patients are treated for their SSIs by other healthcare providers and 
are thus not readmitted to the index hospital. This means that the SSIs would not 
have been detected with passive PDS, 144-149 unless health information can be 
collected from other data sources. 
 
Some recent studies show that between 50% and 95% of SSIs are detected after 
discharge from hospital,104,150-154 but this proportion varies with different PDS 
intensities and between surgical procedure types. In paper I we found that 81% of the 
SSIs following all procedures in NOIS-SSI were detected after discharge. The 
original HELICS protocol did not specify any specific form of PDS.41 However, in the 
subsequent ECDC protocol,43 a variable for collecting information on the method of 
post-discharge surveillance was introduced. The countries which do perform post-
discharge surveillance do this in a multitude of ways ranging from passive to active 
and voluntary to mandatory.59,97,98,120,155,156 
 
Although the NHSN reduced PDS duration following hip arthroplasty from one year to 
90 days in 2013,66,157 we concluded in paper III that 90-day PDS was not an option in 
Norway because this would not be in line with ECDC definitions. However, a very 
recent Dutch study has revealed that ECDC intends to adopt 90-day PDS.158 They 
found that a shortened PDS duration from one year to 90 days would result in 5-6% 
of SSIs following total hip arthroplasties being missed. Similarly, a US study157 shows 
that about 9% of SSIs would be lost by reducing PDS duration from one year to 90 
days for hip arthroplasty. Our data indicate that 7% of SSIs would be missed by 
reducing active PDS from one year to 90 days. However, our data also show that the 
same would be the case by adopting 30 days active PDS followed by passive PDS 
up to 90 days. 
 
The Dutch conclude that PDS intensity is of more importance than PDS duration in 
detecting SSIs, which we also find is true for the first 30 days, but thereafter this is 
not the case. Another argument for 90-day PDS is the timeliness of the feedback of 
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data as compared with one year. In Norway, we collect data at both 30 days and one 
year which enables us to give timely feedback after 30 days of follow-up. It is unclear 
whether other countries have similar practices, with two separate follow-up points. It 
is this practice that has prompted us to recommend 30 day active PDS followed by 
passive PDS up to one year, because the data collection burden on healthcare 
personnel is doubled by active PDS by patient questionnaire at two separate points 
in time. 
4.4.2 Case classification 
As of now, we have not validated actual case-finding in the hospitals in NOIS-SSI. In 
an evaluation of validity of HAI classification in our semi-annual prevalence surveys, 
we found 69% sensitivity and 96% specificity in two Norwegian hospitals.159 
However, this study included several types of HAIs, not exclusively SSIs. Several 
studies have validated SSI surveillance data by chart review, which has traditionally 
been considered to be the “gold standard”.71,77,160-164 Most found high sensitivity and 
all found very high specificity and high positive predictive values (PPVs) and negative 
predictive values (NPVs), which indicated that case classifications were robust and 
correctly applied (Table 5). Interestingly, inter-rater agreement studies have found 
poor consistency between health care professionals in evaluating case-vignettes for 
SSIs18,165,166 or HAIs in general.167 There may be several reasons for this 
discrepancy. One reason may be a form of confirmation bias in the validation studies, 
where the investigator is more partial to seek confirmation of existing classifications. 
Another reason may be that case vignettes may provide abbreviated case 
descriptions, thereby limiting the ability to interpret the case correctly. There are also 
indications that some aspects of case-classification are more difficult than others, 
especially the severity of the infection,163,168,169 and that CDC’s surveillance definition 
criteria for superficial SSI are difficult to apply.170,171 There is a substantial ongoing 
effort in finding reliable automated and semi-automated methods for detecting SSIs 
as an alternative or supplement to the traditional case-finding by ICPs, which I will 
discuss in the next section of this thesis. 
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Table 5. Validation studies by chart review 
 Sensitivity Specificity PPV NPV 
Cardo, 1993162 84 100 97* 99* 
McCoubrey, 200577 97 99 95 99 
Huotari, 2007160 95* 98* 94 99 
Mannien, 2007161 96* 99* 97 99 
Friedman, 2007163 62 100 91* 98* 
Wilson, 201371 91 99 91 99 
Reilly, 2015164 98 100 98 100 
* Calculated based on data in the article 
4.5 The role of information technology in surveillance 
The use of computers in surveillance of HAI has been topic of discussion for over 30 
years. Since the time of the Study on the Efficacy of Nosocomial Infection Control 
(SENIC) until the present, the ability of computers to generate alerts and enhanced 
screening for HAI and thereby reducing time spent on manual tasks such as case-
finding has been a topic of discussion.61 The time and effort saved by computer-
aided HAI surveillance was documented by Evans et al in 1986,172 showing a 65% 
reduction in time spent as compared with traditional case-finding methods. 
Automated data collection is becoming a very important tool in surveillance of 
HAI.75,173 Much has happened in the area of EHRs and data linkage since the 1980s 
and much is presently being done with regard to automated HAI case-finding, 
ranging from searching for codes in administrative or laboratory data to advanced 
computer algorithms which utilize several sources.80,139-141,174,175 
4.5.1 Types of electronic case-finding 
Woeltje176 makes a distinction between two basic types of electronic surveillance 
systems; electronically assisted surveillance and fully electronic surveillance. The 
first is a system that electronically tags possible cases, but still requires human 
interaction to confirm or reject the presence of an SSI according to surveillance 
definitions. This type of system will favor sensitivity over specificity because manual 
review will remove the false positives. The second, which is fully automatic, only 
requires computer algorithms to define whether the surveillance definition has been 
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met. Such systems may use only in-hospital data, or may utilize data from medical 
claims, health maintenance organizations, and other external data sources. 
 
NOIS-SSI does not fit either of these definitions despite being highly automated, 
because there is no automated case-finding in NOIS-SSI. We still consider it an 
electronic system, because the hospitals’ ICMs harvest relevant procedure codes 
and risk-adjustment variables (denominator data) and display these in a user 
interface. Some of the hospital systems require the discharging physician to enter 
infection status before the patient can be discharged (and for the hospital to be 
refunded for the procedure). The patient letters are also partially automated. They 
are generated automatically and most systems include a bar code which identifies 
the patient so that it can be easily appended to the patient record in the ICM when 
returned by mail. 
4.5.2 Positive aspects of automated case-finding 
In the 1980s, Evans et al172 found that the computer-aided method detected 85% of 
the SSIs, while ICPs detected only 58%. Although traditional case-finding by ICPs 
has been considered the "gold standard" of HAI surveillance, several newer studies 
show that this is not necessarily the case: computer-aided surveillance may be more 
time-efficient and superior in case-finding. Many studies have compared traditional 
surveillance by ICPs with case-finding using surveillance definitions to available data 
sources such as ICD-9 diagnostic codes and other administrative coding;78,81,87,89,177-
181 microbiology, laboratory or pharmacy data;182-185 or a combination of 
these84,137,146,184,186-189. Some have utilized advanced algorithms to detect SSIs and 
validate these against ICP case-finding.83,88,185,190-199 
 
Computer systems should reduce the workload on ICPs, thereby making all-year 
surveillance of several procedures an achievable goal for surveillance systems. 
Gathering more standardized data is another opportunity which may arise from 
electronic surveillance, and may be useful in generating more objective 
benchmarking between hospitals.177,197,200-202 Automated data collection may be less 
prone to inter-rater differences and may help alleviate "surveillance fatigue", and 
thereby ensure more consistent data over time.  
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4.5.3 Challenges in automated case-finding 
There are some issues to overcome if more automated case-finding is to be used in 
regular SSI surveillance. Traditional SSI surveillance definitions do not necessarily 
match the clinical definitions which are coded in the electronic systems, and may 
need revision if we are to rely more heavily on available electronic health records. 
This can be partially overcome by advanced algorithms which mimic the surveillance 
definitions. 
 
Automated systems which solely rely upon in-hospital data (inpatients and re-
hospitalizations) will not detect the large and probably increasing portion of the SSIs 
which are detected by other healthcare providers such as general practitioners and 
other hospitals.203 Advances in data mining, data linkage and electronic surveillance 
systems make post-discharge patient information more easily obtainable than 
previously.204-206 This means that the distinction between active and passive PDS will 
be blurred, and that passive PDS may become more sensitive in the 
future.88,89,141,191,203,207,208 Regardless of degree of automation and data sources, 
passive PDS requires high quality systems for data harvesting and good and uniform 
coding practices by health care personnel.155 Additionally, using data for a purpose 
for which they were not intended can mean that they are not appropriate for the 
task.209-211 
 
Despite numerous studies and reviews describing the benefits of electronic case-
finding in HAI surveillance80,139-141,174,202,212 only a handful of systems of this type are 
actually in use in regular clinical routine,174,213,214 and only some of these are applied 
in an SSI-surveillance setting. To the best of my knowledge, no national or statewide 
surveillance system depends solely on electronic detection of SSIs. One can only 
speculate regarding the reason for this. One reason may be the sheer complexity of 
the systems and the data.211,215 Other reasons may be human factors such as the 
ICPs understanding of automated surveillance processes, financial and leadership 
support, the perception of data as meaningful, and acceptance that some issues 
cannot be solved by automated systems.216  
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4.6 Limitations and methodological considerations 
There are several important limitations to the findings in this thesis. We have not 
done a study in the hospitals to validate the application of the surveillance definitions 
by the hospital staff. Although other countries have found good results in such 
validation studies, we cannot be certain that the same would apply in Norway. 
Interpretation of the risk-adjustment variable definitions may not be consistent 
between hospitals. Different IT-system suppliers and system owners may interpret 
the surveillance protocol and specifications differently. They may also be influenced 
to make modifications to the system, such as implementing default values, which 
make surveillance less labor intensive, but corrupts the system. 
 
There may be differences in case mix because not all hospitals submit data each 
year. Norway is a small country, and with only three months of the year under 
surveillance, the numbers are small and results may be uncertain. Patient 
questionnaires, as defined by NOIS-SSI, may not be the optimal way of detecting 
SSIs after hospital discharge. However, there is no alternative method available 
which would ensure better detection at present. 
 
The data in paper II are not linked, but compared on an aggregated level. We cannot 
be certain that NOIS-SSI is a subset of NPR, as both registers may contain unique 
records. 
 
Paper III only includes hip arthroplasty and results may therefore not apply to other 
types of surgery. The study is restricted to hospitals which have completed one year 
PDS (about half of the hospitals), and may not be representative of all hospitals in 
Norway. Some of the reasons why all the late SSIs were coded as readmitted in 
NOIS-SSI may be due to health care personnel manually checking for readmissions 
after the patient has returned the questionnaire with an SSI indication. They may not 
have been detected by passive PDS alone if the hospital electronic health records 
are not adequately coded and harvested or if the patient is readmitted to another 
hospital. 
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4.7 Concluding remarks and future perspectives 
This thesis gives a comprehensive description of a functioning mandatory, national 
surveillance system, with active post-discharge surveillance, which is largely based 
on automated data extraction form hospital IT-systems. We describe pitfalls and 
potential problem areas to be avoided or adjusted for by others wishing to implement 
such systems. The development of computerized systems is complex and would not 
have been possible without a flexible implementation strategy. We find this is a 
double-edged sword – on one hand the flexibility has made it possible to implement 
advanced computerized systems which give good accuracy. On the other hand this 
flexibility has contributed to the data not being sufficiently representative. By 
highlighting problem areas and discussing others' findings we hope to pave the way 
for more sophisticated automation of SSI surveillance systems in Norwegian 
hospitals. 
 
Documenting NOIS-SSI's representativeness issues has contributed to the 
implementation of all year and all procedure surveillance from 2013. In this way we 
hope to achieve more unbiased results. Investigating and documenting post-
discharge surveillance for one year after hip arthroplasty has led to a 
recommendation to revise the surveillance protocol. Follow-up of hip arthroplasty 
patients beyond 30 days will be passive (through readmissions), rather than active 
(by patient questionnaire). This will hopefully lead to time and costs saved by hospital 
staff and more hospitals completing one year follow-up.  
 
In an update after 25 years,217 Evans concludes that the key elements to the success 
of surveillance systems are clinical ownership, clinically knowledgeable IT-personnel, 
knowledge of the underlying data, continual upgrades of the system, and good 
communication between ICPs and IT-personnel. In light of this, there is still much 
work to be done in order to ensure that NOIS-SSI is functioning optimally. 
 
In order to complete the surveillance circle and alter behavior, clinical ownership and 
informing clinicians about the quality and usefulness of the data are key elements. 
This is closely linked to two issues; the ability of ICPs to communicate outcomes and 
trust in case ascertainment. Both these areas need improvement in NOIS-SSI. 
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Hospital data compared with national data has been sent to the hospitals annually 
from the NIPH. However, better training of ICPs in the use and communication of 
national and local surveillance results is needed.218-220 Another road to clinical 
ownership is use of the data for research. Several publications by clinicians have 
used local surveillance data221-223 and collaborations between clinicians and the 
NIPH have resulted in publications on different SSI-related topics.110,224-227 
Encouraging more use of data for research and a validation study focusing on 
correctness of case ascertainment will hopefully contribute to clinicians using and 
trusting the data. In order to generate more interest in using NOIS data for research, 
linked data on a person-identifiable level is important, and efforts are being made to 
make NOIS person-identifiable. 
 
On a national and regional level, clinically knowledgeable IT-personnel are involved 
in the development and maintenance of NOIS-SSI. Because we basically only have 
three major systems, it is not critical to have clinically knowledgeable IT-personnel at 
each individual hospital. It is, however, necessary to have an on-going dialog with the 
IT-system suppliers to ensure correct specification of data extraction and quality 
control. In Norway this communication needs to be better coordinated between the 
hospitals and Regional Health Authorities. It has been the responsibility of the 
hospitals and regions to purchase and implement IT-systems, and thus it has not 
been the role of the national level (NIPH) to be directly involved in system 
specifications and design. 
 
Knowledge of the underlying data has two aspects; technical and clinical. 
Technically, this knowledge is made difficult by diverging systems at different 
hospitals and continual changes and upgrades in underlying computer systems. 
Clinically, an understanding of the underlying data is necessary for interpretation, 
analysis and quality assurance. We believe that the ICPs in Norway have a good 
understanding of this, but there is always room for improvement. Training of new 
ICPs is an important part of ensuring a stable surveillance system. We have 
experienced that technically competent ICPs are a valuable resource.  
 
Judging by the amount of studies on computer-based and automated systems, the 
future of surveillance will certainly rely more on this type of technology. A heavier 
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surveillance workload on ICPs due to, among other demands, public reporting, 
antimicrobial stewardship programs and patient safety initiatives will leave traditional 
surveillance methods insufficient in meeting demands.   
 
Because we already have good quality computer-based systems in place, Norway is 
in a unique position to begin using computer-assisted case-finding in hospitalized 
and re-hospitalized patients. However, data from other sources such as general 
practitioners are not easily accessible at present, but may be in the future. An 
interesting project would be to develop an algorithm for case-finding for use in 
Norwegian hospitals.  
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Background 20 
High quality of surveillance systems for surgical site infections (SSIs) is the key to their 21 
usefulness. The Norwegian Surveillance System for Antibiotic Consumption and Healthcare-22 
Associated Infections (NOIS) was introduced by regulation in 2005, and is based largely on 23 
automated extraction of data from underlying systems in the hospitals. 24 
 25 
Methods 26 
This study investigates the quality of NOIS-SSI’s denominator data by evaluating 27 
completeness, representativeness and accuracy compared with de-identified administrative 28 
data for 2005-2010. Comparisons were made by region, hospital type and size, age and sex 29 
for 4 surgical procedures. 30 
 31 
Results 32 
The completeness of NOIS improved from 29.2% in 2005 to 79.8% in 2010. NOIS-SSI 33 
became representative over time for most procedures by hospital size and type, but not by 34 
region. It was representative by age and sex for all years and procedures. Accuracy was 35 
good for all years and procedures by all explanatory variables. 36 
 37 
Conclusions 38 
A flexible and incremental implementation strategy has encouraged the development of 39 
computer-based surveillance systems in the hospitals which gives good accuracy, but the 40 
same strategy has adversely affected the completeness and representativeness of the 41 
denominator data. For the purpose of evaluating risk factors and implementing prevention 42 
and precautionary measures in the individual hospitals, representativeness seems sufficient, 43 
but for benchmarking and/or public reporting it is not good enough. 44 
 45 
Keywords 46 
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Infection control  50 
Abstract
 3
Surveillance of surgical site infections (SSIs) is increasingly regarded as a cornerstone in 51 
infection prevention. Many hospitals and countries have successfully implemented 52 
surveillance systems [1]. High quality of the systems is a prerequisite for their usefulness. 53 
National surveillance of SSIs in Norway was established with the Norwegian Surveillance 54 
System for Antibiotic Consumption and Healthcare-Associated Infections (NOIS) Act [2] in 55 
2005, and we have earlier reported in detail on the rationale and functioning of this system 56 
[3, 4]. NOIS is based on the Hospital in Europe Link for Infection Control through 57 
Surveillance (HELICS) [5] which was transferred to the European Centre for Disease 58 
Prevention and Control (ECDC) [6], and the definitions from the Centers for Disease Control 59 
and Prevention's (CDC's) National Healthcare Safety Network (NHSN) [7]. 60 
 61 
Describing and evaluating the performance of a surveillance system is key to understanding 62 
its potential usefulness for public health authorities, hospitals, surgeons and hospital 63 
epidemiologists [8]. Validating the quality of the denominator data are important in order to 64 
ensure correct incidence rates and proportions. The objective of this study is to investigate 65 
denominator data quality by comparing surgical site infection surveillance data from NOIS-66 
SSI with administrative data from the Norwegian Patient Register (NPR). We compare de-67 
identified denominator data for the years 2005-2010 on an aggregated level in order to 68 
identify possible discrepancies in terms of completeness, representativeness and accuracy, 69 
and to recommend improvements. 70 
NPR was established in 1997 and contains information on all patients who receive specialist 71 
health care in Norway. Upon treatment in a hospital, an outpatient clinic or by a contracted 72 
private specialist, a series of data are recorded at the treatment site and transmitted to NPR 73 
three times a year. The objective of NPR is to form a basis for administration, management 74 
and quality assurance in specialist health care services, including financing and funding 75 
hospitals [9]. It is considered to be the complete database for hospital care in Norway [10]. 76 
NPR-data are harvested electronically from the hospital electronic health records (EHR). It is 77 
operated by the Norwegian Directorate of Health. The NPR-data in the present study include 78 
variables for all admissions related to the procedure under observation: Patient identifier (de-79 
identified), procedure code  (Nordic Medico-Statistical Committee's Classification of Surgical 80 
Background
Methods
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Procedures (NCSP))[11], diagnosis codes (International Classification of Diseases (ICD10)), 81 
dates and times of admission, discharge and procedure, length of stay, year of birth, sex, 82 
type of admission and hospital identifier. 83 
 84 
NOIS was established in 2005 and is a national, mandatory surveillance system for health-85 
care institutions [2]. The objective of the system is to describe the occurrence of healthcare-86 
associated infections by time and other characteristics, detect outbreaks, provide a basis for 87 
preventive measures, and to evaluate such measures. It is coordinated by the Norwegian 88 
Institute of Public Health (NIPH) in collaboration with the hospitals. The first NOIS-module 89 
encompasses SSIs following several common surgical procedures, and is described in-depth 90 
in our previous publication [3]. Data are collected during an annual three-month surveillance 91 
period (September-November). The data are de-identified by replacing the personal identifier 92 
with a serial number before the annual submission to the NIPH. The surveillance system 93 
relies to a great extent on automatic extraction of patient data from EHRs. There are three 94 
major suppliers of electronic infection control modules (ICMs) in use in Norway. In addition 95 
some hospitals have self-developed systems, some have manual systems and some have a 96 
combined manual and electronic system. 97 
 98 
The following surgical procedures are included in this study (in order of priority in NOIS-SSI): 99 
coronary artery bypass graft (CABG), cesarean section (CSEC), hip prosthesis (HPRO) and 100 
cholecystectomy (CHOL). During the first few years of NOIS-SSI, exemption from submitting 101 
surveillance data was given to hospitals so that they could establish suitable ICMs. Through 102 
2009 hospitals were required to submit data from at least one of the surgical procedures 103 
under surveillance, and from 2010 and onwards at least two procedures [3]. Mixed CABG 104 
procedures (where aorta or ventricle surgery where performed in addition to bypass) were 105 
excluded in 2008 and mixed CHOL procedures (where other procedures are performed 106 
during the same surgery) were excluded in 2007 and 2008. NOIS-SSI includes data on the 107 
following variables of interest for this study; dates of admission, discharge and surgery, 108 
NCSP codes, age, sex, and hospital identifier.  109 
 110 
We define a hospital as a single physical unit/location. A health care trust is a legal entity, 111 
often including several hospitals. There is a trend towards hospitals reporting data on a trust 112 
level. This causes the "hospital type" to be an ambiguous categorization over time, as one 113 
trust may include several different hospital types in the latter years. We have manually 114 
categorized hospitals according to ECDC classifications [6] as follows: primary (district 115 
hospital), secondary (provincial hospital), tertiary (university hospital), and specialized (non-116 
profit/idealistic, private, contracted hospitals that mostly perform elective surgery within 117 
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certain procedure types single specialty). Hospital size was also manually categorized and is 118 
influenced by the same issues as hospital type with regard to reporting on a trust level the 119 
latter years. Regions are designated according to the official categories, South-East, West, 120 
Central and North. Type of ICM was manually coded into four categories according to 121 
whether the NOIS-SSI data for a specific year was generated from of one of the three ICM 122 
suppliers (A, B or C), or from a manual or in-house system (other). 123 
 124 
NOIS-SSI contains the patient's actual age in years on the date of surgery, but the NPR-data 125 
only provides the year of birth. To correct for this, we calculated age by generating pseudo-126 
random birth months (1-12) and days (1-28) for the NPR procedures in order to spread the 127 
patients evenly throughout the year. In surveillance of SSIs, the denominator is the number 128 
of surgical procedures performed. One patient may undergo several procedures, such 129 
bilateral or staged hip replacement which counts as 2 procedures. 130 
 131 
The NPR-data received had one record per admission related to the surgical procedure. We 132 
converted this to one record per procedure based on the patient identifier, year of birth, sex, 133 
hospital identifier and date of surgery. Missing procedure dates in NPR (especially 2009) 134 
were substituted by date of admission. We excluded procedures which were duplicates, had 135 
invalid surgical procedure codes or were from private clinics with inconsistent data in both 136 
registers. In addition we excluded procedures from NOIS-SSI which were outside the 3-137 
month surveillance window, and procedures from NPR from outside 2005-2010. NOIS-SSI 138 
data were appended to NPR-data for data analysis purposes. 139 
 140 
We evaluated the data quality of NOIS-SSI with regard to the completeness, 141 
representativeness and accuracy of the denominator data compared with NPR. We defined 142 
completeness as the total number of procedures in NOIS-SSI divided by the total number of 143 
procedures in NPR during the 3-month surveillance period for each procedure and year. 144 
Representativeness was assessed by comparing the distribution of data in NOIS-SSI with 145 
the distribution of data in NPR by hospital type and size, region, age and sex for each 146 
procedure and year. We defined accuracy as the agreement of data from hospitals and 147 
months which were present in both registers. We thus excluded data from hospitals or 148 
months which were not present in both registers from the comparison and divided the 149 
number of procedures in NOIS-SSI by NPR. We further compared the distributions in the two 150 
registers by the same variables as for representativeness. In addition we evaluated the 151 
accuracy based on the type of ICM used for collecting NOIS-SSI data. Frequencies were 152 
calculated for each of the surgical categories for each year, the whole period, and for each 153 
included variable. NOIS-SSI was evaluated against NPR in terms of percentages and chi-154 
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squared analysis. All data cleaning and analysis was done using Stata v.11 (Stata Statistical 155 
Software, College Station, TX). The study has been approved by the Regional Committee for 156 
Medical and Health Research Ethics. It does not require patient consent as both NPR and 157 
NOIS are national health registers governed by separate acts. 158 
After data cleaning 162,509 procedures remained from NPR for 2005-2010, whereof 45,347 159 
(27.9%) from September - November. From NOIS-SSI, 26,250 procedures were included 160 
from September-November of 2005-2010. 161 
 162 
Table 1 shows completeness as the number of procedures submitted to NOIS-SSI divided by 163 
the total number of procedures in NPR for the 3-month surveillance period in 2005-2010. For 164 
the whole period, NOIS-SSI encompassed 57.9% of the total number of surgical procedures 165 
in NPR. The overall completeness improved from 29.2% in 2005 to 79.8% in 2010. 166 
 167 
Figure 1 shows the representativeness of NOIS-SSI by comparing the distribution of the 168 
procedures in NOIS-SSI with NPR by hospital size for each year. During the first years of 169 
operation NOIS-SSI differed significantly from NPR. As more hospitals submitted data during 170 
the subsequent years the distributions became more similar and thus more representative for 171 
most procedures. There was similar pattern by hospital type (data not shown), and the 172 
differences between registers cease to be significant for CABG from 2008 and for CSEC 173 
from 2009. For HPRO, only 2009 had no significant differences between the registers. For 174 
CHOL the differences are significant for all years by hospital type. By region (data not 175 
shown) the differences in distribution between NOIS-SSI and NPR were greater. Only CABG 176 
in 2008 and 2009 and CSEC in 2010 had no significant differences. There were no 177 
significant differences in distribution by age and sex between NOIS-SSI and NPR (p>0.05). 178 
The median age was about 66 for CABG, 31 for CSEC, 73 for HPRO and 49 for CHOL. 179 
 180 
Table 2 shows the accuracy of NOIS-SSI compared with NPR by surgical procedure and 181 
year, for hospitals and reporting months which were present in both registers. Overall 182 
accuracy was 94.8%, the lowest was 2008 with 90.6% and the highest was 2010 with 97.5%. 183 
The procedures with the highest overall accuracy were HPRO and CSEC. There were no 184 
significant differences in distribution by region, hospital type and size, age or sex for each 185 
year and procedure (p>0.05) between NOIS-SSI and NPR. 186 
 187 
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Figure 2 shows the development of ICMs from one major supplier and several manual and 188 
in-house systems in 2005, to most data from major ICM suppliers in 2010. All ICMs and other 189 
systems in the hospitals perform well, and we only find significant differences between NOIS-190 
SSI and NPR for CSEC in 2008 (p=0.001). System B had the highest overall accuracy 191 
(97.5%). The three commercial systems demonstrate less variability than manual/other 192 
systems but the differences were not significant (p>0.05). 193 
The Norwegian Surveillance System for Antibiotic Consumption and Healthcare-Associated 194 
Infections (NOIS-SSI) included 79.8% of the procedures in the administrative data during 195 
September-November 2010, up from 29.2% in 2005. NOIS-SSI was not representative with 196 
regard to hospital size and type during the earliest years, but became representative with 197 
time for some procedures. NOIS-SSI was representative with regard to age and sex for all 198 
years and procedures. The accuracy was 97.5% in 2010, an increase from 92.7% in 2005 199 
and there were no differences in the distribution by any explanatory variables, except by type 200 
of infection control module (ICM) for CSEC in 2008. 201 
 202 
Comparing denominator data between two registers gives an indication of the quality of the 203 
data in both registers. It also reflects the quality of the data extraction at the individual 204 
hospital. Denominator data are important in order to reliably describe infection occurrence on 205 
a national level, in hospital benchmarking, and inter-country comparisons. Regardless of how 206 
diligent numerator (infection) case finding is, incidence proportions only make sense if the 207 
correct denominator is used [12]. In a recent review, Goto [13] investigated the accuracy of 208 
administrative coding, but none of the included SSI-related studies reported on the quality of 209 
denominator data. McCoubrey [14] found that 91% of eligible procedures were included in 210 
the Scottish surveillance data. Haley [15] found 98% matches between administrative- and 211 
surveillance data. Most validation studies report only on the numerator in terms of infection 212 
as outcome. A number of studies have investigated the completeness of other Norwegian 213 
health registers compared with NPR. Among these, 0.4% more CSECs were found in the 214 
Medical Birth Register of Norway [16], the Norwegian Vascular Register found a 215 
completeness of 84% for abdominal aortic aneurism repair [17], and the Norwegian 216 
Arthroplasty Register found 97% completeness of primary HPRO compared with NPR [18]. 217 
These studies are important because in addition to ascertaining the quality of the individual 218 
registers, validate the quality of NPR. Although it has improved, NOIS-SSI still only received 219 
78.8% of the procedures performed during September-November 2010. 220 
 221 
Discussion
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Because NOIS-SSI only collected data during September-November during the study period, 222 
it was dependent on those 3 months being representative. The explanatory variables which 223 
reflect hospital participation (region, hospital type and size), show that NOIS-SSI was 224 
generally not representative for most procedures until the last years. There are several 225 
possible explanations for this. 226 
 227 
During the first years, many hospitals were granted exemption from submitting data in order 228 
to facilitate the establishment of ICMs. The ICMs were generally purchased or developed for 229 
whole trusts or regions, which led to several regions submitting little or no data during the 230 
first years. Most hospitals and regions had installed ICMs by 2007, but some were not 231 
functioning optimally. This led to some hospitals and trusts being exempted also in the later 232 
years, and NOIS-SSI not being representative by region. 233 
 234 
During 2005-2009 NOIS-SSI only required data from one procedure, the one with the highest 235 
priority. This means that hospitals were only required to submit data from the highest 236 
prioritized procedure which they performed. All hospitals which performed CABG procedures 237 
were required to submit data, but exemptions were granted to some regions and hospitals 238 
the first years. In addition, some hospitals did not submit data in later years despite it being 239 
required. If a hospital reported on CABG, it did not have to submit any other procedures. In 240 
principle this meant that none of the tertiary hospitals, which almost all performed CABG, 241 
were required to submit CSEC data causing poor representativeness by type of hospital for 242 
CSEC. This also affected representativeness by hospital size, because the tertiary hospitals 243 
are generally the largest. From 2010 a minimum of 2 procedures were required and this 244 
improved the representativeness for CSEC by hospital size and type. However, CSEC 245 
representativeness was already good in 2009, probably attributable to "enthusiastic 246 
volunteers". For HPRO, representativeness by hospital size started improving in 2008. Some 247 
of the hospitals which perform HPRO are specialized orthopedic hospitals, and these have 248 
submitted data consistently over the years. Many other hospitals have submitted HPRO data 249 
voluntarily, and this may explain why representativeness started improving before the 250 
implementation of minimum 2 procedures in 2010. For CHOL representativeness was 251 
generally poor, which is to be expected as this procedure had the lowest surveillance priority. 252 
For age and sex NOIS-SSI was representative, meaning that there were no differences 253 
between NOIS-SSI and NPR in the patient population for these variables. 254 
 255 
In a review of four surveillance systems Haustein et al [19] recommended mandatory 256 
reporting in order to assure that data are not biased. They found that none of the voluntary 257 
systems they investigated ever surpassed 50% participation, and that representativeness 258 
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improved when reporting was made mandatory. NOIS-SSI was mandatory since inception, 259 
but a flexible implementation policy (granting exemptions) caused it not to be representative 260 
on a national level and caused participant population to change over time. The additional 261 
complication of hospitals changing from individual hospital to trust level reporting produces 262 
data which is less useful for stratification and risk purposes. This is demonstrated in Figure 1, 263 
where a greater proportion of large hospitals are evident during the latter years. For example, 264 
2 small primary hospitals and 1 large tertiary hospital reported individually until 2008 and 265 
from 2009 they reported as one large trust on the tertiary level. 266 
 267 
The importance of representative surveillance data depends on how data are to be used. For 268 
evaluating risk factors and implementing preventive measures in the individual hospitals, 269 
NOIS-SSI seems to provide useful data. For hospital benchmarking and/or public reporting, 270 
NOIS-SSI was not good enough. 271 
 272 
We found the agreement between the two registers to be good, which means that when the 273 
hospitals did submit data to NOIS-SSI they appeared to be accurate. We only observed a 274 
significant difference (p=0.001) between the registers by ICM for CSEC in 2008, which was 275 
mainly due to technical issues in two hospitals with the same ICM-supplier resulting in 276 
incomplete data extraction. Another reason for somewhat lower accuracy in some 277 
procedures and years was that the NOIS-SSI protocol was modified with regard to mixed 278 
procedures. The exclusion of the mixed CABG procedures in 2008 gave a dip in the 279 
accuracy of NOIS-SSI (not significant). For CHOL, exclusion of mixed procedures did not 280 
appear to influence accuracy, which is reasonable because over 90% of CHOLs were 281 
laparoscopic procedures [20] and generally not mixed (Table 2). 282 
 283 
Automated data collection is becoming a very important tool in surveillance of HAI. It reduces 284 
the workload on hospital staff and, hopefully, human errors [21-30]. In NPR all data are 285 
collected electronically from the hospitals' EHR and in NOIS-SSI most explanatory and 286 
background variables are collected electronically, so we expect denominator data to be 287 
identical. As demonstrated by the lower accuracy in CSEC for 2008, one cannot be certain 288 
that denominator data are correct even if they are extracted directly from hospital computer 289 
systems. Computer systems are not infallible, and it is necessary to routinely check if data 290 
are being harvested correctly. We observe some variability between the ICMs and other 291 
systems and it appears that the accuracy overall for the ICMs was more consistent than the 292 
manual/other systems, but none of the differences were significant. 293 
 294 
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The development of ICMs is complex and would have been more difficult without a flexible 295 
implementation strategy. As shown in Figure 2, the hospitals quite quickly purchased or 296 
developed ICMs. We found the flexible implementation to be a double-edged sword. On one 297 
side the flexibility made good cooperation with hospitals and ICM suppliers possible and has 298 
led to quality ICMs which give good accuracy. On the other side this flexibility contributed to 299 
less representative data. Although NOIS-SSI is mandatory, the flexible implementation 300 
introduced selection bias giving poor representativeness for variables that reflect hospital 301 
participation. 302 
 303 
NOIS-SSI improved over the first six years, but data were still not fully complete and 304 
representative in 2010. The accuracy of NOIS-SSI was good, because the hospitals which 305 
submitted data have had consistently good denominator quality throughout the years, with a 306 
few exceptions. We also saw an indication that automated data harvesting gave slightly 307 
better denominator data quality. It is, however, difficult to assess true completeness, 308 
representativeness and accuracy without having access to linked data [31]. Being able to 309 
compare surveillance data with administrative data on a regular basis, in order to give 310 
hospitals feedback on data quality, could be a useful tool in improving quality and instilling 311 
trust in the surveillance system performance. Some have argued that administrative systems 312 
can provide more economical, standardized and unbiased outcome data than traditional 313 
surveillance systems if used correctly [32-34]. 314 
 315 
The data in this study are not linked and are compared on an aggregated level. We cannot 316 
be certain that NOIS-SSI is a subset of NPR, as both registers may contain unique records. 317 
Some variables were coded manually by the authors, and may contain unintentional errors. 318 
Birth month and date for the NPR data were generated by a pseudo-random function and 319 
does not reflect different annual birth rate patterns. For calculation of accuracy some 320 
hospitals and months were excluded from analysis, and this may give an incorrect 321 
impression of the quality of NOIS-SSI. 322 
NOIS-SSI had a completeness of 79.8% of the procedures in the administrative data (NPR). 323 
The NOIS-SSI denominator data were not representative by hospital size and type during the 324 
first years of surveillance system operation, but became representative for some procedures 325 
with time. NOIS-SSI was generally not representative by region. This means that data from 326 
this period should not be used for hospital benchmarking and/or public reporting. NOIS-SSI 327 
was representative by age and sex for all procedures. For the purpose of evaluating risk 328 
Conclusions
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factors and implementing prevention and precautionary measures in the individual hospitals, 329 
representativeness seems sufficient. Denominator data agreement between NOIS-SSI and 330 
NPR of almost 95% indicates that the accuracy of submitted data of was good. A flexible and 331 
incremental implementation strategy has encouraged development of computer-based 332 
surveillance systems in hospitals which gives good accuracy, but has adversely affected the 333 
representativeness of the data during the first years of system operation. 334 
 335 
Table 1. Completeness: The number of procedures by type of surgical procedure and year 336 
and proportion of the procedures in NOIS versus NPR, September-November 2005-337 
2010. 338 
  2005 2006 2007 2008 2009 2010 Total 
CABG               
NOIS 167 599 680 718 746 612 3,522 
NPR 1,067 1,006 1,046 928 817 796 5,660 
Completeness 15.7 % 59.5 % 65.0 % 77.4 % 91.3 % 76.9 % 62.2 % 
CSEC               
NOIS 883 1,322 1,634 1,948 2,171 2,484 10,442 
NPR 2,210 2,304 2,443 2,513 2,509 2,586 14,565 
Completeness 40.0 % 57.4 % 66.9 % 77.5 % 86.5 % 96.1 % 71.7 % 
HPRO               
NOIS 903 1,052 1,338 1,853 2,522 2,565 10,233 
NPR 2,621 2,628 2,870 2,776 3,106 3,141 17,142 
Completeness 34.5 % 40.0 % 46.6 % 66.8 % 81.2 % 81.7 % 59.7 % 
CHOL               
NOIS 166 234 339 342 409 563 2,053 
NPR 1,356 1,308 1,394 1,362 1,285 1,275 7,980 
Completeness 12.2 % 17.9 % 24.3 % 25.1 % 31.8 % 44.2 % 25.7 % 
TOTAL completeness 29.2 % 44.3 % 51.5 % 64.1 % 75.8 % 79.8 % 57.9 % 
NOIS: Norwegian Surveillance System for Antibiotic Consumption and Healthcare-Associated Infections 
NPR: Norwegian Patient Register             
 339 
 340 
Figure 1. Representativeness: Proportion of procedures  (in %) by hospital size in NOIS 341 
and NPR (2005-2010) 342 
 343 
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Table 2. Accuracy: The number of procedures by type of surgical procedure and year and 344 
proportion of the procedures in NOIS versus NPR for selected hospitals and reporting 345 
months, 2005-2010. 346 
  2005 2006 2007 2008 2009 2010 Total 
CABG1 
NOIS 167 402 519 580 503 520 2,691 
NPR 237 446 589 709 514 554 3,049 
Accuracy 70.5 % 90.1 % 88.1 % 81.8 % 97.9 % 93.9 % 88.3 % 
CSEC 
NOIS 883 1,304 1,607 1,826 2,051 2,402 10,073 
NPR 904 1,346 1,660 2,014 2,065 2,431 10,420 
Accuracy 97.7 % 96.9 % 96.8 % 90.7 % 99.3 % 98.8 % 96.7 % 
HPRO 
NOIS 903 1,052 1,338 1,853 2,151 2,335 9,632 
NPR 943 1,087 1,451 1,959 2,194 2,363 9,997 
Accuracy 95.8 % 96.8 % 92.2 % 94.6 % 98.0 % 98.8 % 96.3 % 
CHOL1 
NOIS 159 234 339 341 405 524 2,002 
NPR 194 274 359 395 464 582 2,268 
Accuracy 82.0 % 85.4 % 94.4 % 86.3 % 87.3 % 90.0 % 88.3 % 
TOTAL accuracy 92.7 % 94.9 % 93.7 % 90.6 % 97.6 % 97.5 % 94.8 % 
NOIS: Norwegian Surveillance System for Antibiotic Consumption and Healthcare-Associated Infections 
NPR: Norwegian Patient Register 
1
 Mixed procedures excluded from NOIS for CABG in 2008 and for CHOL in 2007 and 2008 
 347 
Figure 2. Proportion of hospitals submitting data to NOIS from different electronic 348 
systems (A, B and C) and other data sources, 2005-2010 349 
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